Van Eck Associates Corp Dr Reddys Laboratories LTD Transaction History
Van Eck Associates Corp
- $80.1 Billion
- Q3 2024
A detailed history of Van Eck Associates Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 823 shares of RDY stock, worth $12,929. This represents 0.0% of its overall portfolio holdings.
Number of Shares
823
Previous 501
64.27%
Holding current value
$12,929
Previous $38,000
68.42%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RDY
# of Institutions
245Shares Held
23.1MCall Options Held
12.7KPut Options Held
6.1K-
Morgan Stanley New York, NY2.24MShares$35.2 Million0.01% of portfolio
-
Robeco Institutional Asset Management B.V.2.07MShares$32.4 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62MShares$31.3 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$30.6 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$28.3 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.61B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...